Advertisement

Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 600x94px
Document › Details

AB Science S.A.. (4/30/15). "Press Release: 2014 Revenues of 2,099 K€. Clinical Trial with Masitinib in 13 Phase 3 Studies". Paris.

Organisations Organisation AB Science S.A. (NYSE Euronext - FR0010557264 - AB)
  Group AB Science (Group)
  Organisation 2 bpifrance
  Group France (govt)
Products Product masitinib
  Product 2 clinical research
     


   
Record changed: 2017-04-02

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

More documents for AB Science (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 600x94px




» top